"If successfully developed, ravidasvir could help treat millions of hepatitis C patients and we are pleased to work with Pharco to ensure the availability of affordable versions," said Greg Perry, Executive Director of the Medicines Patent Pool.
"Chronic hepatitis C affects approximately 71 million people globally, with Egypt suffering from one of the highest burdens," said Dr. Sherine Helmy, CEO of Pharco Pharmaceuticals. "RAV, in combination with other hepatitis C treatments, could support new national as well as global goals to eliminate the virus."
MPP's agreement expands the geographic scope of a licence signed by Presidio, the original developer of RAV, and the Drugs for Neglected Diseases initiative (DNDi) in March 2016, extending coverage to several LMICs that were not included in the DNDi licence. Combined, the MPP and DNDi agreements could potentially benefit countries where 85.3% of people live with hepatitis C in the 139 block of economies classified by the World Bank as low- and middle-income.
JAC Recruitment is a truly international company. Founded in London in 1975 and extending our footprint to Asia in 1987, we are the longest established international recruitment company group in the region. We place high caliber professionals, many with specialist language abilities, across all major multinational companies in the Asia region and beyond.
Our network of businesses spans 25 offices in 10 countries, across Asia and the U.K. and Japan. We are more than 1,000 professional consultants worldwide, specialists in our industries who believe in making connections. Take the first step in finding that perfect connection for you - search our job vacancies now.
Pharmiweb.com RSS Feeds
PharmiWeb Candidate Blog
PharmiWeb Client Blog
Sarkari Naukri in Rajasthan 2017 Latest Upcoming Govt Jobs in Rajasthan |Recruitment, Result, Application Form, Admit Card
Federal University Wukari
moallim e urdu vacancy job